American College of Cardiology20d
Discontinuing Drug Treatment in HFrEF, Race and Sacubitril/Valsartan Use in HF, Systolic BP Polygenic Risk Score Treatment Responses
He then explores the effect of race and sacubitril/valsartan use in HF patients documented in a pooled analysis of the PARADIGM-HF and PARAGON-HF trials. Finally, Dr. Eagle discusses the utility of ...
BMJ27d
Tolerability and beneficial effects of sacubitril/valsartan on systemic right ventricular failure
Pharmacological options for sRV failure remain poorly defined. This study aims to investigate the tolerability and effects of sacubitril/valsartan on sRV failure in adult patients with sRV. Methods In ...
ahajournals.org1mon
Abstract TP21: Efficacy and Safety of Sacubitril/Valsartan in Patients with Acute Ischemic Stroke and Hypertension within 24-72 hours
Introduction： The efficacy of blood pressure (BP) reduction of Sacubitril/valsartan has been proved in hypertension patients, yet not in patients with acute ischemic stroke (AIS). We aimed to ...